140
Participants
Start Date
December 1, 2023
Primary Completion Date
December 1, 2028
Study Completion Date
December 1, 2029
treatment of TKI in CML
continued treatment with TKI at randomization a then stopped treatment 12 months after randomization
RECRUITING
Chu Angers, Angers
ACTIVE_NOT_RECRUITING
Ch Annecy, Annecy
RECRUITING
Ch Bayonne, Bayonne
RECRUITING
Chu Brest, Brest
RECRUITING
CH Brive la Gaillarde, Brive-la-Gaillarde
ACTIVE_NOT_RECRUITING
Ch Chambery, Chambéry
RECRUITING
CHI Creteil, Créteil
RECRUITING
Ch La Rochelle, La Rochelle
RECRUITING
Chu Lille, Lille
RECRUITING
CHU Limoges, Limoges
RECRUITING
Centre Léon Bérard, Lyon
RECRUITING
Ch Mont de Marsan, Mont-de-Marsan
ACTIVE_NOT_RECRUITING
Chu Nancy, Nancy
RECRUITING
Chu Nantes, Nantes
ACTIVE_NOT_RECRUITING
Hopital Prive Du Confluent, Nantes
RECRUITING
Ch Perigueux, Périgueux
RECRUITING
Chu Poitiers, Poitiers
RECRUITING
Oncopole Toulouse, Toulouse
RECRUITING
Chu Tours, Tours
RECRUITING
CH Versailles, Versailles
Poitiers University Hospital
OTHER